Sanuwave Health Inc (SNWV) — Titan Protect Analysis

SNWV

Sanuwave Health Inc

Healthcare · ·

$14.76

Data: 2026-06-03

✓ ETHICAL PASS

NONE MOAT

LIMITED

Data Confidence: 0.0%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$130M

Total market value of the company

Trailing P/E

15.78

Reasonably valued

Forward P/E

-1,515.00

Based on estimated future earnings — lower means cheaper

Rev Growth

+3.1%

Year-over-year revenue change

Profit Margin

37.2%

How much profit the company keeps from each dollar of revenue

ROE

N/A

Return on equity — how efficiently it uses shareholder money

Analyst Target

N/A

Recommendation

NONE

Consensus view from ? analysts covering this stock

About Sanuwave Health Inc

SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company markets UltraMist system, a medical device that uses non-thermal ultrasound to treat tissues using a fluid mist to transmit energy in a non-contact and pain

https://sanuwave.com

Country: United States Employees: 55 Industry: Medical Devices

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% PENDING

Debt must be below 33% of total assets

Cash Ratio

0.0% PENDING

Interest-bearing cash below 33% of assets

Receivables

0.0% PENDING

Receivables below 49% of assets

Revenue Purity

0.0% PENDING

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

MARKUP

Price trending up with increasing momentum

Sharpe Ratio

0.508

Good returns relative to risk taken

Kelly Fraction

0.0275

Modest edge detected — smaller position warranted

Calmar Ratio

0.164

Drawdown risk outweighs the returns — higher risk profile

Annual Return

10.9%

Historical annualised return based on price data

Max Drawdown

-66.5%

Largest peak-to-trough decline — the worst it has been

HMM State

BULL

Statistical model sees bullish momentum

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

1.36

Moves slightly more than the broader market

52W High

$46.59

68% below the year high

52W Low

$14.90

-1% above the year low

Avg Volume

92,273

Average daily shares traded — higher means easier to buy and sell

Short Ratio

7.0

Days it would take all short sellers to cover — higher means more crowded

Short % Float

N/A

Div Yield

N/A

Annual dividend as a percentage of the share price

EPS (TTM)

$0.96

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

1,205.88

Heavy leverage — higher financial risk if revenues decline

Current Ratio

N/A

Quick Ratio

N/A

Like current ratio but excludes inventory — stricter test

Gross Margin

76.7%

Revenue left after cost of goods — higher means pricing power

Operating Margin

-11.7%

Profit from core operations before interest and tax

Free Cash Flow

$-5,503,000

Negative — the business is spending more than it generates

Revenue (TTM)

$44M

Total revenue over the last 12 months

Net Income

$16M

Profitable — the bottom line is positive

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-06-03

Before you go